RESUMO
The human brain can efficiently process action-related visual information, which supports our ability to quickly understand and learn others' actions. The visual information of goal-directed action is extensively represented in the parietal and frontal cortex, but how actions and goal-objects are represented within this neural network is not fully understood. Specifically, which part of this dorsal network represents the identity of goal-objects? Is such goal-object information encoded at an abstract level or highly interactive with action representations? Here, we used functional magnetic resonance imaging with a large number of participants (n = 94) to investigate the neural representation of goal-objects and actions when participants viewed goal-directed action videos. Our results showed that the goal-directed action information could be decoded across much of the dorsal pathway, but in contrast, the invariant goal-object information independent of action was mainly localized in the early stage of dorsal pathway in parietal cortex rather than the down-stream areas of the parieto-frontal cortex. These results help us to understand the relationship between action and goal-object representations in the dorsal pathway, and the evolution of interactive representation of goal-objects and actions along the dorsal pathway during goal-directed action observation.
Assuntos
Mapeamento Encefálico , Lobo Parietal , Humanos , Mapeamento Encefálico/métodos , Lobo Parietal/diagnóstico por imagem , Imageamento por Ressonância Magnética/métodos , Encéfalo/diagnóstico por imagemRESUMO
OBJECTIVE: The fabrication of bioactive coatings on metallic implants to enhance osseointegration has become a topic of general interest in orthopedics and dentistry. Hydroxyapatite (HA) coating has been shown to induce bone formation and promote bone-implant integration. Unfortunately, poor mechanical performance has hindered this from becoming a favorable coating material. The majority of present studies have focused in incorporating different elements into HA coatings to improve mechanical properties. In recent years, tantalum (Ta) has received increasing attention due to its excellent biocompatibility and corrosion resistance. The aim of on the present study was to investigate the fabrication and biological performance of Ta-incorporated HA coatings. METHODS: Ta-incorporated HA coatings were fabricated using the plasma spray technique on a titanium substrate, and the surface characteristics and mechanical properties were examined. In addition, the effects of Ta-incorporated HA coatings on the biological behavior of mesenchymal stem cells (BMSCs) were investigated. RESULTS: Ta-incorporated HA coatings with microporous structure had higher roughness and wettability. In addition, the bonding strength of Ta/HA coatings with the substrate was substantially superior to HA coatings. Furthermore, Ta-incorporated HA coatings not only facilitated initial cell adhesion and faster proliferation, but also promoted the osteogenic differentiation of BMSCs. CONCLUSION: These results indicate that the incorporation of Ta could improve mechanical performance and increase the osteogenic activity of HA coatings. The Ta-incorporated HA coating fabricated by plasma spraying is expected to be a promising bio-coating material for metallic implants.
Assuntos
Materiais Biocompatíveis/química , Durapatita/química , Osteogênese , Tantálio/química , Titânio/química , Animais , Adesão Celular , Diferenciação Celular/efeitos dos fármacos , Proliferação de Células , Células Cultivadas , Materiais Revestidos Biocompatíveis/química , Corrosão , Teste de Materiais , Células-Tronco Mesenquimais/citologia , Metais , Osseointegração , Porosidade , Pós , Próteses e Implantes , Desenho de Prótese , Ratos , Ratos Sprague-Dawley , Estresse Mecânico , Propriedades de SuperfícieRESUMO
Alzheimer's disease (AD) is an incurable neurodegenerative disease and many types of stem cells have been used in AD therapy with some favorable effects. In this study, we investigated the potential therapeutical effects of human dental pulp stem cells (hDPSCs) on AD cellular model which established by okadaic acid (OA)-induced damage to human neuroblastoma cell line, SH-SY5Y, in vitro for 24 h. After confirmed the AD cellular model, the cells were co-culture with hDPSCs by transwell co-culture system till 24 h for treatment. Then the cytomorphology of the hDPSCs-treated cells were found to restore gradually with re-elongation of retracted dendrites. Meanwhile, Cell Counting Kit-8 assay and Hoechst 33258 staining showed that hDPSCs caused significant increase in the viability and decrease in apoptosis of the model cells, respectively. Observation of DiI labeling also exhibited the prolongation dendrites in hDPSCs-treated cells which were obviously different from the retraction dendrites in AD model cells. Furthermore, specific staining of α-tubulin and F-actin demonstrated that the hDPSCs-treated cells had the morphology of restored neurons, with elongated dendrites, densely arranged microfilaments, and thickened microtubular fibrils. In addition, results from western blotting revealed that phosphorylation at Ser 396 of Tau protein was significantly suppressed by adding of hDPSCs. These results indicate that hDPSCs may promote regeneration of damaged neuron cells in vitro model of AD and may serve as a useful cell source for treatment of AD.
Assuntos
Células-Tronco Adultas/citologia , Doença de Alzheimer/terapia , Polpa Dentária/transplante , Células-Tronco Adultas/metabolismo , Doença de Alzheimer/metabolismo , Diferenciação Celular/fisiologia , Movimento Celular/fisiologia , Proliferação de Células/fisiologia , Células Cultivadas , Técnicas de Cocultura/métodos , Polpa Dentária/citologia , Polpa Dentária/metabolismo , Humanos , Modelos Biológicos , Neuroblastoma/metabolismo , Neurônios/metabolismo , Neurônios/fisiologia , Cultura Primária de Células/métodos , Transplante de Células-TroncoRESUMO
Diabetes mellitus involves metabolic changes that can impair bone repair. Bone mesenchymal stem cells (BMSCs) play an important role in bone regeneration. However, the bone regeneration ability of BMSCs is inhibited in high glucose microenvironments. It can be speculated that this effect is due to changes in BMSCs' proliferation and migration ability, because the recruitment of factors with an adequate number of MSCs and the microenvironment around the site of bone injury are required for effective bone repair. Recent genetic evidence has shown that the Cyclin D1 and the CXC receptor 4 (CXCR-4) play important roles in the proliferation and migration of BMSCs. In this study we determined the specific role of glycogen synthase kinase-3ß (GSK3ß) in the proliferation and migration of BMSCs in high glucose microenvironments. The proliferation and migration ability of BMSCs were suppressed under high glucose conditions. We showed that high glucose activates GSK3ß but suppresses CXCR-4, ß-catenin, LEF-1, and cyclin D1. Inhibition of GSK3ß by LiCl led to increased levels of ß-catenin, LEF-1, cyclin D1, and CXCR-4 expression. Our data indicate that GSK3ß plays an important role in regulating the proliferation and migration of BMSCs by inhibiting cyclin D1 and CXCR-4 under high glucose conditions.
Assuntos
Osso e Ossos/citologia , Movimento Celular/efeitos dos fármacos , Microambiente Celular/efeitos dos fármacos , Glucose/farmacologia , Glicogênio Sintase Quinase 3 beta/metabolismo , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/enzimologia , Animais , Proliferação de Células/efeitos dos fármacos , Separação Celular , Ciclina D1/metabolismo , Ativação Enzimática/efeitos dos fármacos , Feminino , Glicogênio Sintase Quinase 3 beta/antagonistas & inibidores , Fator 1 de Ligação ao Facilitador Linfoide/metabolismo , Células-Tronco Mesenquimais/efeitos dos fármacos , Ratos Sprague-Dawley , Receptores CXCR4/metabolismo , beta Catenina/metabolismoRESUMO
Cordycepin is a bioactive component of the fungus Cordyceps militaris. Previously, we showed that cordycepin can alleviate hyperlipidemia through enhancing the phosphorylation of AMP-activated protein kinase (AMPK), but the mechanism of this stimulation is unknown. Here, we investigated the potential mechanisms of cordycepin-induced AMPK activation in HepG2 cells. Treatment with cordycepin largely reduced oleic acid (OA)-elicited intracellular lipid accumulation and increased AMPK activity in a dose-dependent manner. Cordycepin-induced AMPK activation was not accompanied by changes in either the intracellular levels of AMP or the AMP/ATP ratio, nor was it influenced by calmodulin-dependent protein kinase kinase (CaMKK) inhibition; however, this activation was significantly suppressed by liver kinase B1 (LKB1) knockdown. Molecular docking, fluorescent and circular dichroism measurements showed that cordycepin interacted with the γ1 subunit of AMPK. Knockdown of AMPKγ1 by siRNA substantially abolished the effects of cordycepin on AMPK activation and lipid regulation. The modulating effects of cordycepin on the mRNA levels of key lipid regulatory genes were also largely reversed when AMPKγ1 expression was inhibited. Together, these data suggest that cordycepin may inhibit intracellular lipid accumulation through activation of AMPK via interaction with the γ1 subunit.
Assuntos
Proteínas Quinases Ativadas por AMP/química , Desoxiadenosinas/farmacologia , RNA Mensageiro/genética , Quinases Proteína-Quinases Ativadas por AMP , Proteínas Quinases Ativadas por AMP/genética , Proteínas Quinases Ativadas por AMP/metabolismo , Monofosfato de Adenosina/metabolismo , Trifosfato de Adenosina/metabolismo , Quinase da Proteína Quinase Dependente de Cálcio-Calmodulina/antagonistas & inibidores , Quinase da Proteína Quinase Dependente de Cálcio-Calmodulina/genética , Quinase da Proteína Quinase Dependente de Cálcio-Calmodulina/metabolismo , Desoxiadenosinas/química , Relação Dose-Resposta a Droga , Ativação Enzimática , Regulação da Expressão Gênica , Células Hep G2 , Humanos , Metabolismo dos Lipídeos/efeitos dos fármacos , Simulação de Acoplamento Molecular , Ácido Oleico/farmacologia , Fosforilação , Inibidores de Proteínas Quinases/farmacologia , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Proteínas Serina-Treonina Quinases/genética , Proteínas Serina-Treonina Quinases/metabolismo , RNA Mensageiro/metabolismo , RNA Interferente Pequeno/genética , RNA Interferente Pequeno/metabolismo , Transdução de SinaisRESUMO
Microbial transformation of the oleanolic acid (1) using Trichothecium roseum (pers.) Link (M 95.56) has resulted in the isolation of two new hydroxylated type metabolites, characterized as 15α-hydroxy-3-oxo-olean-12-en-28-oic acid (2) and 7ß,15α-dihydroxy-3-oxo-olean-12-en-28-oic acid (3). The structure elucidation of these metabolites was based primarily on HR-EIMS, 1D NMR, and 2D NMR analyses.
Assuntos
Hypocreales/metabolismo , Ácido Oleanólico/metabolismo , Estrutura Molecular , Ressonância Magnética Nuclear Biomolecular , Ácido Oleanólico/químicaRESUMO
The self-assembly of collagen within the human body creates a complex 3D fibrous network, providing structural integrity and mechanical strength to connective tissues. Recombinant collagen plays a pivotal role in the realm of biomimetic natural collagen. However, almost all of the reported recombinant collagens lack the capability of self-assembly, severely hindering their application in tissue engineering and regenerative medicine. Herein, we have for the first time constructed a series of self-assembling tyrosine-rich triple helix recombinant collagens, mimicking the structure and functionality of natural collagen. The recombinant collagen consists of a central triple-helical domain characterized by the (Gly-Xaa-Yaa)n sequence, along with N-terminal and C-terminal domains featuring the GYY sequence. The introduction of GYY has a negligible impact on the stability of the triple-helical structure of recombinant collagen while simultaneously promoting its self-assembly into fibers. In the presence of [Ru(bpy)3]Cl2 and APS as catalysts, tyrosine residues in the recombinant collagen undergo covalent cross-linking, resulting in a hydrogel with exceptional mechanical properties. The recombinant collagen hydrogel exhibits outstanding biocompatibility and bioactivity, significantly enhancing the proliferation, adhesion, migration, and differentiation of HFF-1 cells. This innovative self-assembled triple-helix recombinant collagen demonstrates significant potential in the fields of tissue engineering and medical materials.
Assuntos
Colágeno , Hidrogéis , Proteínas Recombinantes , Tirosina , Tirosina/química , Humanos , Colágeno/química , Hidrogéis/química , Proteínas Recombinantes/química , Proliferação de Células/efeitos dos fármacos , Adesão Celular/efeitos dos fármacos , Engenharia Tecidual/métodos , Linhagem Celular , Movimento Celular/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Materiais Biocompatíveis/químicaRESUMO
The development of efficacious bone substitute biomaterials remains a major challenge for research and clinical surgical. Herein, we constructed triple helix recombinant collagen (THRC) -based hydrogels loading bone morphogenetic protein-2 (BMP-2) to stimulate bone regeneration in cranial defects. A series of in situ forming hydrogels, denoted as THRC-oxidized carboxymethylcellulose (OCMC)-N-succinyl-chitosan (NSC) hydrogels, was synthesized via a Schiff base reaction involving OCMC, THRC and NSC. The hydrogels underwent rapid formation under physiological pH and temperature conditions. The composite hydrogel exhibits a network structure characterized by uniform pores, the dimensions of which can be tuned by varying THRC concentrations. The THRC-OCMC-NSC and THRC-OCMC-NSC-BMP2 hydrogels display heightened mechanical strength, substantial biodegradability, and lower swelling properties. The THRC-OCMC-NSC hydrogels show exceptional biocompatibility and bioactivity, accelerating cell proliferation, adhesion, and differentiation. Magnetic resonance imaging, computed tomography and histological analysis of rat cranial defects models revealed that the THRC-OCMC-NSC-BMP2 hydrogels substantially promote new bone formation and expedite bone regeneration. The novel THRC-OCMC-NSC-BMP2 hydrogels emerge as promising candidates for bone substitutes, demonstrating substantial potential in bone repair and regeneration applications.
Assuntos
Proteína Morfogenética Óssea 2 , Regeneração Óssea , Colágeno , Hidrogéis , Animais , Ratos , Materiais Biocompatíveis , Substitutos Ósseos , Quitosana/química , Hidrogéis/químicaRESUMO
Prolonged exposure to UV radiation can cause severe photodamage to the skin, leading to abnormal fragmentation of elastin fibers. As one of the main protein components of the dermal extracellular matrix, elastin plays a critical role in the mechanical behavior and physiological function of the skin. Animal-derived elastin has attracted extensive attention in tissue engineering, however it suffers from severe drawbacks such as a risk of virus transmission, ready degradation, and challenging quality control. Herein, we have for the first time developed a novel recombinant fusion elastin (RFE) and its cross-linked hydrogel for improved healing efficacy for UV-irradiated skin. RFE showed temperature-sensitive aggregation behavior similar to natural elastin. Compared with recombinant elastin without the fusion V-foldon domain, RFE showed a much more ordered secondary structure and lower transition temperature. Furthermore, Native-PAGE results indicated that the addition of the V-foldon domain triggered the formation of remarkable oligomers in RFE, which may result in a more ordered conformation. Tetrakis Hydroxymethyl Phosphonium Chloride (THPC) cross-linking of RFE led to the production of a fibrous hydrogel with uniform three-dimensional porous nanostructures and excellent mechanical strength. The RFE hydrogel showed superior cellular activity, significantly promoting the survival and proliferation of human foreskin fibroblast-1 (HFF-1). Studies of mice models of UV-irradiated skin demonstrated that the RFE hydrogel pronouncedly accelerated their healing process by inhibiting epidermal hyperplasia as well as boosting the regeneration of collagen and elastin fibers. The highly biocompatible and bioactive recombinant fusion elastin and its cross-linked hydrogel provide a potent treatment for photodamaged skin, which may have promising applications in dermatology and tissue engineering.
Assuntos
Elastina , Hidrogéis , Camundongos , Humanos , Animais , Temperatura de Transição , Elastina/farmacologia , Elastina/química , Elastina/metabolismo , Hidrogéis/farmacologia , Hidrogéis/química , Raios Ultravioleta , Pele/metabolismoRESUMO
Due to its excellent biocompatibility and corrosion resistance, tantalum demonstrates versatility as an implant material. However, limited studies investigated the role of tantalum coated titanium-based dental implants. This study aimed to investigate the potential application of micro-nano porous structured tantalum coating on the surface of titanium dental implant. In the present study, micro-nano porous structured tantalum coating was prepared by vacuum plasma spraying (VPS) under selected optimum parameters, various characteristics of tantalum coating (Ta/Ti), including the morphology, potential, constituent, and hydrophilia, were investigated in comparison with its respective control groups, sandblasted titanium (Ti) and titanium coating (Ti/Ti). The adhesion, proliferation, and osteogenic differentiation ability of rat bone marrow mesenchymal cells (BMSCs) on different materials were assessed in vitro. Then the osseointegration capacity of Ti, Ti/Ti, Ta/Ti, and Straumann implants in canine mandible was evaluated with micro-CT, histological sections, and energy dispersive X-ray spectroscopy. These results demonstrated that micro-nanostructured, uneven, and granular tantalum coating was successfully prepared on titanium substrate by VPS with pore size ranging from 50 nm to 5 µm and thickness ranging from 80 to 100 µm. Tantalum coating revealed the highest surface potential, best hydrophilia, and most protein adsorption among Ta/Ti, Ti/Ti, and Ti. Furthermore, Ta/Ti surfaces significantly promoted the adhesion, proliferation, and osteogenic differentiation of BMSCs. In vivo, Ta/Ti implants displayed positive osseointegration capability associated with increased bone mineral density and formation of new bone around implants without tantalum particles released. Together, these findings indicate that tantalum-coated titanium dental implants may serve as a new type of dental implant.
Assuntos
Implantes Dentários , Osseointegração , Ratos , Animais , Osteogênese , Titânio/farmacologia , Titânio/química , Tantálio/farmacologia , Tantálio/química , Propriedades de SuperfícieRESUMO
BACKGROUND: Chimeric antigen receptor (CAR) T cell therapy has shown promising results in treating blood cancers, but it has limited efficacy against solid tumors that express mesothelin (MSLN). One of the reasons is the immunosuppressive tumor microenvironment, which consists of physical barriers, multiple mechanisms of immune evasion, and various biochemical factors that favor tumor growth and survival. These factors reduce the antitumor activity of MSLN-targeted CAR T cells in clinical trials. Therefore, new therapeutic strategies are needed to enhance the effectiveness of MSLN-targeted CAR T cell therapy. METHODS: To investigate whether the antitumor efficacy of anti-MSLN CAR-T cells depends on the epitopes they recognize, we generated MSLN-targeted CAR T cells that bind to different regions of MSLN (Region I, II, III and Full length). We then evaluated the antitumor activity of MSLN-targeted CAR T cells alone or in combination with the chemotherapeutic drug irinotecan or an anti-PD-1 antibody in vitro and in vivo. RESULTS: We found that MSLN-targeted CAR T cells effectively killed MSLN-positive cancer cells (H9, H226 and Panc-1), but not MSLN-negative cells (A431) in vitro. In a mouse model of H9 tumor xenografts, all CAR T cells showed similar tumor suppression, but an MSLN-targeted scFv with Region I epitope, R47, performed slightly better. Combining irinotecan with CAR_R47 T cells enhanced tumor control synergistically in both H9 xenograft mice and patient-derived xenograft mice. CONCLUSIONS: Our results suggest that irinotecan can enhance the antitumor activity of MSLN-targeted CAR T cells, and offer a promising combination therapy strategy for MSLN-positive solid tumors.
Assuntos
Neoplasias , Receptores de Antígenos Quiméricos , Humanos , Animais , Camundongos , Mesotelina , Imunoterapia Adotiva/métodos , Irinotecano , Proteínas Ligadas por GPI/metabolismo , Linhagem Celular Tumoral , Modelos Animais de Doenças , Neoplasias/tratamento farmacológicoRESUMO
The synthesis of calcium carbonate with controlled morphology is crucial for its biomedical applications. In this study, we synthesized well-ordered porous calcium carbonate nanospheres using recombinant collagen as a biomineralization template. Porous collagen-calcium carbonate was created by incubating calcium chloride and sodium carbonate with collagen biotemplates at room temperature. Our results show that the recombinant collagen-calcium carbonate nanomaterials underwent a morphological transition from solid nanospheres to more porous nanospheres and a phase transformation from vaterite to a mixture of calcite and vaterite. This study highlights the crucial role of recombinant collagen in modulating the morphology and crystallinity of calcium carbonate nanoparticles. Importantly, the highly porous recombinant collagen-calcium carbonate hybrid nanospheres demonstrated superior loading efficacy for the model drug cefoperazone. Furthermore, the drug loading and releasing results suggest that hybrid nanospheres have the potential to be robust and biocompatible pH-responsive drug carriers. Our findings suggest that recombinant collagen's unique amino acid content and rodlike structure make it a superior template for biomineralized synthesis. This study provides a promising avenue for the production of novel organic-inorganic nanostructures, with potential applications in biomedical fields such as drug delivery.
RESUMO
How to efficiently regenerate jawbone defects caused by trauma, jaw osteomyelitis, tumors, or intrinsic genetic diseases is still challenging. Ectoderm-derived jawbone defect has been reported to be regenerated by selectively recruiting cells from its embryonic origin. Therefore, it is important to explore the strategy for promoting ectoderm-derived jaw bone marrow mesenchymal stem cells (JBMMSCs) on the repair of homoblastic jaw bone. Glial cell-derived neurotrophic factor (GDNF) is an important growth factor and is essential in the process of proliferation, migration and differentiation of nerve cells. However, whether GDNF promoting the function of JBMMSCs and the relative mechanism are not clear. Our results showed that activated astrocytes and GDNF were induced in the hippocampus after mandibular jaw defect. In addition, the expression of GDNF in the bone tissue around the injured area was also significantly increased after injury. Data from in vitro experiments demonstrated that GDNF could effectively promote the proliferation and osteogenic differentiation of JBMMSCs. Furthermore, when implanted in the defected jaw bone, JBMMSCs pretreated with GDNF exhibited enhanced repair effect compared with JBMMSCs without treatment. Mechanical studies found that GDNF induced the expression of Nr4a1 in JBMMSCs, activated PI3K/Akt signaling pathway and then enhanced the proliferation and osteogenic differentiation capacities of JBMMSCs. Our studies reveal that JBMMSCs are good candidates for repairing jawbone injury and pretreated with GDNF is an efficient strategy for enhancing bone regeneration.
Assuntos
Células-Tronco Mesenquimais , Osteogênese , Fator Neurotrófico Derivado de Linhagem de Célula Glial/metabolismo , Fator Neurotrófico Derivado de Linhagem de Célula Glial/farmacologia , Proteínas Proto-Oncogênicas c-akt/metabolismo , Fosfatidilinositol 3-Quinases/metabolismo , Diferenciação Celular , Proliferação de Células , Células-Tronco Mesenquimais/metabolismo , Células da Medula Óssea , Células CultivadasRESUMO
This study aims to present a sustainably releasing system of exosomes-fibrin combinate loaded on tantalum-coating titanium implants. We hope to investigate potential effects of the system on osseointegration between tantalum coating titanium implants and its surrounding bone tissue. Exosomes derived from rabbit bone marrow stromal cells (rBMSCs) and fibrin were deposited onto the micro-nanostructure tantalum coating surface (Ta + exo + FI) and compared to control groups, including tantalum coating (Ta), tantalum coating loaded exosomes (Ta + exo) and tantalum coating loaded fibrin (Ta + FI). The optimal concentration of loading exosomes, exosomes uptake capacity by BMSCs, and the effect of controlled-release by fibrin were assessed by laser scanning confocal microscope (LCSM) and microplate reader. The optimal concentration of exosomes was 1 µg/µL. Adhesion, proliferation, and osteogenic differentiation ability of BMSCs on different materials were assessed in vitro. Finally, osseointegrative capacity of Ta, Ta + exo, Ta + FI, Ta + exo + FI implants in rabbit tibia were respectively evaluated with histology and bone-implant contact ratio (BIC%). It was demonstrated that exosome sustained-release system with fibrin loading on the tantalum coating was successfully established. Fibrin contribute to exosomes release extension from 2d to 6d. Furthermore, Ta + exo + FI significantly promoted adhesion, proliferation, and osteogenic differentiation of BMSCs. In vivo, the implants in Ta + exo + FI group displayed the highest osseointegrative capability than those in other groups. It is concluded that this exosome delivery system on the implants may be an effective way for tantalum coating titanium implants to promote osseointegration between implant and its surrounding bone tissue.
RESUMO
Acute and persistent infection of Epstein-Barr virus (EBV) is associated with several life-threatening hematological disorders, including lymphoproliferative disorders (LPD), hemophagocytic lymphohistiocytosis (HLH), and chronic active Epstein-Barr virus infection (CAEBV). Currently, there are no efficacious virus-targeted therapies for EBV-driven hematological diseases. To explore the potential of phagocytosis-based immunotherapy, we created a bispecific antibody by targeting the viral envelope protein gp350 with a novel EBV-neutralizing antibody (named R1) that was paired with a monoclonal antibody against CD89 for redirecting macrophages and neutrophils. In vitro study showed that the bispecific antibody enabled efficient phagocytosis of EBV and killing of gp350 + lymphoma cells in the presence of PBMC. In vivo studies in NSG mice inoculated with EBV showed that bispecific antibody dramatically reduced the viral load in blood, solid organs and tissues. Treatment of mice implanted with EBV-harboring Raji lymphoma cells efficiently prevented tumor formation and massive metastasis to solid organs. Treatment of mice implanted with whole blood from EBV-HLH patients was effective in reducing viral levels in blood and solid organ. The gp350/CD89 bispecific antibody was highly effective in clearing EBV and immunotherapy of EBV-driven hematological diseases such as LPD and EBV-HLH.
Assuntos
Infecções por Vírus Epstein-Barr , Herpesvirus Humano 4 , Animais , Camundongos , Infecções por Vírus Epstein-Barr/terapia , Infecções por Vírus Epstein-Barr/complicações , Leucócitos Mononucleares , Anticorpos Antivirais , ImunoterapiaRESUMO
NEL-like molecule 1 (NELL1) is a potent osteogenic factor associated with craniosynostosis. Adenoviruses, the most commonly used viral vectors for gene therapy, have several disadvantages that may restrict osteogenesis. Previous studies have shown that lentiviruses can serve as ideal vectors for gene therapy for bone regeneration. In this study, two lentiviral vectors (LvNELL1 and LvBMP2) that encode human NELL1 and bone morphogenetic protein-2 (BMP2), respectively, were constructed. The effect of LvNELL1 infection on the proliferation, osteogenesis, and adipogenesis of human adipose-derived stem cells (hADSCs) in vitro was assessed and compared with that of LvBMP2. The results showed that hADSCs infected with LvNELL1 could efficiently and stably overexpress the target genes. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay results demonstrated that LvBMP2, but not LvNELL1, enhanced the proliferation of hADSCs. Assessment of alkaline phosphatase activity and cellular mineralization indicated that LvNELL1 infection promoted the osteogenic differentiation of hADSCs, and the effect was comparable with that of LvBMP2. Real-time polymerase chain reaction (PCR) revealed that LvNELL1 infection upregulated OSX expression but not RUNX2 expression in hADSCs. In addition, adipogenic markers (lipid droplets, peroxisome proliferator-activating receptor γ, and lipoprotein lipase) analysis showed that LvNELL1 could dramatically inhibit the adipogenic differentiation of hADSCs, but LvBMP2 had no such effect. Taken together, these findings suggested that lentiviral-mediated NELL1 gene transfer in hADSCs may be a novel and promising approach to achieve effective and precise bone regeneration.
Assuntos
Proteína Morfogenética Óssea 2/genética , Lentivirus/genética , Proteínas do Tecido Nervoso/genética , Células-Tronco/metabolismo , Adipócitos/citologia , Adipócitos/metabolismo , Adipogenia/genética , Tecido Adiposo/citologia , Adulto , Western Blotting , Proteína Morfogenética Óssea 2/metabolismo , Proteínas de Ligação ao Cálcio , Diferenciação Celular/genética , Células Cultivadas , Expressão Gênica , Técnicas de Transferência de Genes , Vetores Genéticos/genética , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Células HEK293 , Humanos , Lipase Lipoproteica/genética , Lipase Lipoproteica/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Osteogênese/genética , PPAR gama/genética , PPAR gama/metabolismo , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fator de Transcrição Sp7 , Células-Tronco/citologia , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismoRESUMO
PURPOSE: The aim of this study was to determine whether local insulin delivery using a fibrin gel (FG) loaded with insulin/poly(lactic-co-glycolic acid) microspheres (FGIPM) improves the biomechanical retention of titanium implants in type 1 diabetic rats. MATERIALS AND METHODS: Rats were divided randomly into 8 groups: a group of healthy rats (no treatment), a group of diabetic rats (no treatment), and 6 groups of diabetic rats treated locally using carriers containing or not containing insulin. Rats received implants in the tibia and were allowed to heal for 4 or 8 weeks. Removal torque tests (RTQ) were performed to evaluate the biomechanical retention of the implants. RESULTS: In the diabetic control group, the mean RTQ values were significantly decreased compared with those for the healthy group. The local application of FGIPM increased the RTQ values in diabetic rats to the values found in the healthy rats at 8 weeks. The FG-treated group presented statistically significant higher mean RTQ values than the diabetic rats receiving no treatment. CONCLUSIONS: Local insulin delivery using FGIPM ameliorated the biomechanical retention of titanium implants in type 1 diabetic rats and the FG had a beneficial effect.
Assuntos
Implantes Dentários , Materiais Dentários/química , Retenção em Prótese Dentária , Diabetes Mellitus Experimental/complicações , Diabetes Mellitus Tipo 1/complicações , Sistemas de Liberação de Medicamentos , Fibrina , Hipoglicemiantes/administração & dosagem , Insulina/administração & dosagem , Ácido Láctico , Ácido Poliglicólico , Titânio/química , Administração Tópica , Animais , Fenômenos Biomecânicos , Preparações de Ação Retardada , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Tipo 1/tratamento farmacológico , Portadores de Fármacos , Fibrina/química , Hipoglicemiantes/farmacocinética , Insulina/farmacocinética , Ácido Láctico/química , Masculino , Microscopia Eletrônica de Varredura , Microesferas , Placebos , Ácido Poliglicólico/química , Copolímero de Ácido Poliláctico e Ácido Poliglicólico , Distribuição Aleatória , Ratos , Ratos Wistar , Estreptozocina , Fatores de Tempo , TorqueRESUMO
Diffuse large B-cell lymphoma not otherwise specified (DLBCL-NOS) is a subtype of large B-cell non-Hodgkin lymphoma with various clinical and pathological manifestations. DLBCL-NOS which primarily arises from maxillary sinus is rare and hard to diagnose due to unique anatomy. Here, we present a case of DLBCL-NOS that developed in the left maxillary sinus of a 72-year-old male, who presented with severe toothache that resembled acute pulpitis. The lesion was diagnosed and treated based on radiographs, histological, immunohistological examinations, and PET-CT analysis. Despite its rare incidence, DLBCL-NOS should still be included in differential diagnoses to rule out malignancy in cases of endodontic disease.
RESUMO
The discovery of efficient photocatalysts is a promising key approach to solve the environmental crisis caused by hazardous organic dyes. Herein, we have for the first time created ZnO mesocrystals with a novel apple-like morphology. We have developed a one-pot biomineralization route to synthesize ZnO nanostructures at room temperature by using the rod-like protein collagen as the template. The shape of ZnO mesocrystals can be conveniently tuned from fusiform-like and kiwi-like to orange-like, apple-like, and snack-like structures. The apple-like ZnO mesocrystals show a significantly better photodegradation efficiency than the commercial ZnO powder as well as other nanostructured ZnO materials for both rhodamine B (RhB) and methyl orange (MO). Furthermore, the apple-like zinc-oxide mesocrystals can degrade all of the tested eight different types of organic dyes (RhB, rhodamine 6G, methylene blue, Coomassie brilliant blue R250, BPB, MO, Li Chunhong S, and carmine) simply under the exposure of sunlight, demonstrating their superior photodegradation prowess, environmental amiability, and energy-saving features. The novel robust and versatile photocatalyst has greatly advanced our abilities for the elimination of organic dyes. The green, one-pot strategy provides a convenient method for the construction of novel metal-oxide nanostructures with promising applications in environmental protection.
RESUMO
EGFRvâ ¢ is an established target for immunotherapy of glioblastoma (GBM). Current study aims to explore the efficacy of EGFRvâ ¢-targeted immunotoxin combined with temozolomide (TMZ) or T cell-engaged bispecific antibody for the treatment of GBM. We generated three rabbit monoclonal antibodies (R1, R2, and R6) that specifically bound to EGFRvâ ¢, but not EGFR, with high affinity. Immunotoxins were made by fusing the scFv of these antibodies with engineered Pseudomonas exotoxin PE24. The in vitro cytotoxicity and specificity of the immunotoxins was rigorously validated by EGFRvâ ¢ and EGFR-expressed cell lines. The in vivo efficacy of immunotoxin monotherapy and in combination with TMZ or EGFRvâ ¢-targeted bispecific antibody was evaluated in orthotopic and subcutaneous xenograft mouse models. EGFRvâ ¢ immunotoxins potently killed U87, U251 and GL261 cells that were forcefully expressing EGFRvâ ¢, with IC50 values bellow 1.2 ng/ml. In a subcutaneous model, multiple intratumoral injections of immunotoxin at a dose of 2 mg/kg resulted in complete tumor regression in 3/5 of mice. In a C57BL/6 orthotopic glioblastoma model transplanted with GL261 cells that expressed a mouse version of EGFRvâ ¢, two injections of 10 micrograms of immunotoxin in the lateral ventricles significantly improved the survival, with 2/5 mice being completely cured. Furthermore, in a subcutaneous xenograft model transplanted with EGFRvâ ¢-expressed U87 cells, a single intratumoral injection of immuntoxin followed by i.v. injections of TMZ or EGFRvâ ¢-targeted bispecific antibody achieved complete regression in mice. Taken together, EGFRvâ ¢ immunotoxin combined with TMZ or T cell-engaged bispecific antibody offers promise for curative treatment of GBM.